4//SEC Filing
MCNEILL JOHN A JR 4
Accession 0001033408-09-000003
CIK 0001003124other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 11:58 AM ET
Size
20.8 KB
Accession
0001033408-09-000003
Insider Transaction Report
Form 4
MCNEILL JOHN A JR
Director
Transactions
- Award
Stock Options (to buy)
2009-05-20+13,577→ 13,577 totalExercise: $19.86From: 2009-05-20Exp: 2019-05-20→ Common Stock (13,577 underlying)
Holdings
- 365,485(indirect: By Partnership)
Common Stock
- 12,000
Stock Options (to buy)
Exercise: $12.81From: 2002-05-15Exp: 2012-05-14→ Common Stock (12,000 underlying) - 16,000
Stock Options (to buy)
Exercise: $13.58From: 2003-05-14Exp: 2013-05-13→ Common Stock (16,000 underlying) - 16,000
Stock Options (to buy)
Exercise: $15.06From: 2004-05-19Exp: 2014-05-18→ Common Stock (16,000 underlying) - 5,458
Stock Options (to buy)
Exercise: $23.79From: 2005-05-18Exp: 2015-05-17→ Common Stock (5,458 underlying) - 3,973
Stock Options (to buy)
Exercise: $35.38From: 2006-05-17Exp: 2016-05-16→ Common Stock (3,973 underlying) - 6,126
Stock Options (to buy)
Exercise: $33.82From: 2007-05-16Exp: 2017-05-15→ Common Stock (6,126 underlying) - 2,623,571(indirect: By Trust)
Common Stock
- 10,156(indirect: By Trust)
Common Stock
- 1,195(indirect: By LLC)
Common Stock
- 6,265
Stock Options (to buy)
Exercise: $42.77From: 2008-05-21Exp: 2018-05-20→ Common Stock (6,265 underlying) - 16,000
Stock Options (to buy)
Exercise: $4.50From: 2000-05-16Exp: 2010-05-15→ Common Stock (16,000 underlying) - 8,000
Stock Options (to buy)
Exercise: $15.82From: 2001-05-15Exp: 2011-05-14→ Common Stock (8,000 underlying) - 59,713
Common Stock
Documents
Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CIK 0001003124
Entity typeother
Related Parties
1- filerCIK 0001033408
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 11:58 AM ET
- Size
- 20.8 KB